Safety and Efficacy of Oral Administration of the Phage Cocktail, VRELysin™, In Healthy and VRE-Colonized Subjects
Clinical trial NCT05715619 · SUSPENDED
Trial details
- NCT number
- NCT05715619
- Sponsor
- Intralytix, Inc.
- Status
- SUSPENDED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-10-25
- Primary completion
- 2026-10-31
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.